University of Michigan
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT00075114
The purpose of this study is to determine the capacity of self-efficacy to predict maintaining a behavior change at four years post urinary control intervention.
Looking for future studies?
Notify Me55 year–80 year
Female
Interventional
Phase 3
Ann Arbor, Michigan, 48109, United States
This is a study that will monitor and compare attitudes and strategies that women use to maintain behavior changes that prevent urination problems. Women will complete questionnaires, do muscle strength exercises, and bladder training at 3 months, one year, and 4 years post intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion and exclusion criteria
Additional criteria are applied at a physical examination:
A two-hour bladder health class presented by two experts in urinary incontinence and followed by an individual follow-up teaching session with an incontinence nurse specialist.
Time frame: Baseline, 6-, 12-, 18-, 24-, 32-, 42-, 48-months post baseline
Time frame: Baseline, 6-, 12-, 18-, 24-, 32-, 42-, 48-months post baseline
Time frame: Baseline, 6-, 12-, 18-, 24-, 32-, 42-, 48-months post baseline
Time frame: Baseline, 6-, 12-, 18-, 24-, 32-, 42-, 48-months post baseline
Looking for future studies?
Notify MeUniversity of Michigan
Other
Promoting Self -Care to Prevent Urinary Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06450795
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07413692
Behavior, Behavioral Symptoms
Garfield Heights, Ohio, United States
View Trial DetailsNCT06231394
Behavior, Behavioral Symptoms
Izmir, Bornova, Turkey (Türkiye)
View Trial DetailsNCT07151170
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Islamabad, Pakistan
View Trial Details